Comments to FDA: Contract Manufacturing Quality Agreements Share page: Docket Number: FDA-2013-D-0558 CHPA's comments on this Draft Guidance are organized into three General Comments and Detailed Comments by Section. Download Document Issues: OTC Medicines Other Issues Quality Related Posts Press Releases and Statements CHPA Applauds White House Executive Order Prioritizing Lower Drug Costs and Access to Self-Care Apr 17, 2025 Press Releases and Statements CHPA Responds to Section 232 Investigation on Pharmaceuticals Apr 15, 2025 Press Releases and Statements CHPA Commends Lawmakers for Urging FDA to Protect the Rx-OTC-Switch Pathway Apr 11, 2025